Literature DB >> 15528363

The 3' untranslated region of the membrane-bound IL-1R accessory protein mRNA confers tissue-specific destabilization.

Liselotte E Jensen1, Alexander S Whitehead.   

Abstract

IL-1alpha and IL-1beta are proinflammatory cytokines that promote activation of intracellular signaling cascades, leading to stabilization of certain mRNAs and activation of transcription factors. IL-1R type I (IL-1RI) binds IL-1alpha and IL-1beta, and subsequent recruitment of the membrane-bound IL-1R accessory protein (mIL-1RAcP) facilitates signal transduction. Two alternatively spliced isoforms, soluble IL-1RAcP (sIL-1RAcP) and sIL-1RAcP-beta, which lack transmembrane and intracellular domains, have been described. The sIL-1RAcP and possibly sIL-1RAcP-beta can inhibit IL-1 signaling. Proportional expression of the different IL-1RAcP splice variants may be an important determinant of responsiveness to IL-1. We show that although both mIL-1RAcP and sIL-1RAcP mRNAs are widely expressed in human tissue, their relative proportions differ significantly in a tissue-specific manner. Turnover studies revealed that the sIL-1RAcP mRNA has a half-life of approximately 48 h in both the kidney cell line 293 and the hepatoma cell line HepG2. The mIL-1RAcP mRNA has a similar half-life in 293 cells, but a considerably shorter half-life of approximately 5 h in HepG2 cells. Using luciferase reporter constructs, we demonstrated that this specific destabilization of the mIL-1RAcP mRNA in the latter cell type is mediated by its 2.8-kb 3'-untranslated region. Deletion analysis further established that the cell line-specific instability does not involve AU-rich elements, but is mediated by several novel elements that appear to act independently; such elements may be recognized by proteins expressed specifically in some, but not all, tissues. These data demonstrate that the cellular capacity to respond to IL-1 is tightly regulated in a tissue-specific manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528363     DOI: 10.4049/jimmunol.173.10.6248

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia.

Authors:  Nicholas J Hand; Amber M Horner; Zankhana R Master; LaTasha A Boateng; Claire LeGuen; Marina Uvaydova; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-02       Impact factor: 2.839

2.  Toll-like receptor 3 regulates Mx expression in rare minnow Gobiocypris rarus after viral infection.

Authors:  Jianguo Su; Zuoyan Zhu; Yaping Wang; Jun Zou; Wei Hu
Journal:  Immunogenetics       Date:  2008-03-28       Impact factor: 2.846

3.  Characterization of Toll-like receptor 3 gene in rainbow trout (Oncorhynchus mykiss).

Authors:  M F Rodriguez; G D Wiens; M K Purcell; Y Palti
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

4.  Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.

Authors:  Kenneth K W To; Zhirong Zhan; Thomas Litman; Susan E Bates
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

5.  Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity.

Authors:  Kiymet Bozaoglu; Chantal Attard; Hemant Kulkarni; Nik Cummings; Vincent P Diego; Melanie A Carless; Katherine A Shields; Matthew P Johnson; Sudhir Kowlessur; Thomas D Dyer; Anthony G Comuzzie; Laura Almasy; Paul Zimmet; Eric K Moses; Harald H H Göring; Joanne E Curran; John Blangero; Jeremy B M Jowett
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

6.  Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways.

Authors:  Julio C Sanmiguel; Florina Olaru; Jieliang Li; Elisabeth Mohr; Liselotte E Jensen
Journal:  Cell Signal       Date:  2009-01-07       Impact factor: 4.315

7.  Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients.

Authors:  M Wager; J Guilhot; J-L Blanc; S Ferrand; S Milin; B Bataille; F Lapierre; S Denis; T Chantereau; C-J Larsen; L Karayan-Tapon
Journal:  Br J Cancer       Date:  2006-10-23       Impact factor: 7.640

8.  Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP).

Authors:  A Seda Yılmaz-Eliş; Annemieke Aartsma-Rus; Peter Ac 't Hoen; Huma Safdar; Cor Breukel; Bart Jm van Vlijmen; Judith van Deutekom; Sjef de Kimpe; Gert-Jan van Ommen; J Sjef Verbeek
Journal:  Mol Ther Nucleic Acids       Date:  2013-01-22       Impact factor: 10.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.